mRNA-1345 demonstrated vaccine efficacy of 83.7% against RSV lower respiratory tract disease, defined by 2 or more symptoms in older adults
The announcement follows FDA 510(k) clearance of device
The initiative will engage adolescents and youth of India in decisions about their reproductive health
The drug is also intended for the treatment of glioblastoma multiforme
Broadens company’s oncology platform of Targeted Alpha Therapies (TATs)
Subscribe To Our Newsletter & Stay Updated
